Medytox Inc. - Net Worth and Insider Trading

Medytox Inc. Net Worth

The estimated net worth of Medytox Inc. is at least $53 Million dollars as of 2024-09-25. Medytox Inc. is the Former 10% Owner of Evolus Inc and owns about 3,381,326 shares of Evolus Inc (EOLS) stock worth over $53 Million. Details can be seen in Medytox Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Medytox Inc. has not made any transactions after 2023-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Medytox Inc.

To

Medytox Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Medytox Inc. owns 1 companies in total, including Evolus Inc (EOLS) .

Click here to see the complete history of Medytox Inc.’s form 4 insider trades.

Insider Ownership Summary of Medytox Inc.

Ticker Comapny Transaction Date Type of Owner
EOLS Evolus Inc 2023-10-16 10 percent owner

Medytox Inc. Latest Holdings Summary

Medytox Inc. currently owns a total of 1 stock. Medytox Inc. owns 3,381,326 shares of Evolus Inc (EOLS) as of October 16, 2023, with a value of $53 Million.

Latest Holdings of Medytox Inc.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EOLS Evolus Inc 2023-10-16 3,381,326 15.78 53,357,324

Holding Weightings of Medytox Inc.


Medytox Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Medytox Inc. has made a total of 17 transactions in Evolus Inc (EOLS) over the past 5 years, including 8 buys and 9 sells. The most-recent trade in Evolus Inc is the sale of 1,690,663 shares on October 16, 2023, which brought Medytox Inc. around $13 Million.

Insider Trading History of Medytox Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Medytox Inc. Trading Performance

GuruFocus tracks the stock performance after each of Medytox Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Medytox Inc. is -39.95%. GuruFocus also compares Medytox Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Medytox Inc. within 3 months outperforms 0 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Medytox Inc.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Medytox Inc.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -25.92 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -25.46 LIMIT LIMIT LIMIT LIMIT LIMIT

Medytox Inc. Ownership Network

Ownership Network List of Medytox Inc.

No Data

Ownership Network Relation of Medytox Inc.

Insider Network Chart

Medytox Inc. Owned Company Details

What does Evolus Inc do?

Who are the key executives at Evolus Inc?

Medytox Inc. is the 10 percent owner of Evolus Inc. Other key executives at Evolus Inc include Chief Financial Officer Sandra Beaver , Chief Marketing Officer Tomoko Yamagishi-dressler , and director & See Remarks David Moatazedi .

Evolus Inc (EOLS) Insider Trades Summary

Over the past 18 months, Medytox Inc. made 1 insider transaction in Evolus Inc (EOLS) with a net sale of 1,690,663. Other recent insider transactions involving Evolus Inc (EOLS) include a net sale of 701,527 shares made by David Moatazedi , a net sale of 18,581 shares made by Sandra Beaver , and a net sale of 35,076 shares made by Rui Avelar .

In summary, during the past 3 months, insiders sold 8,907 shares of Evolus Inc (EOLS) in total and bought 0 shares, with a net sale of 8,907 shares. During the past 18 months, 2,509,270 shares of Evolus Inc (EOLS) were sold and 174,967 shares were bought by its insiders, resulting in a net sale of 2,334,303 shares.

Evolus Inc (EOLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Evolus Inc Insider Transactions

No Available Data

Medytox Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Medytox Inc.. You might contact Medytox Inc. via mailing address: 78, Gangni 1-gil, Ochang-eup,, Cheongwon-gu, Cheogju-si M5 28126.

Discussions on Medytox Inc.

No discussions yet.